Feature Channels:

Parkinson’s Disease

Add to Favorites Subscribe Share
fbshare-Parkinson’s Disease

Showing results

110 of 133
image001.png
  • Embargo expired:
    17-Jul-2019 1:00 PM EDT

Article ID: 715843

Can gut infection trigger Parkinson’s disease?

Universite de Montreal

Results suggest some forms of PD are an autoimmune disease triggered years before noticeable symptoms

Released:
15-Jul-2019 5:35 PM EDT
Jefferson4CHP3002.jpg

Article ID: 715856

Antioxidant Precursor Molecule Could Improve Parkinson’s

Thomas Jefferson University

The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson’s Disease

Released:
16-Jul-2019 8:05 AM EDT
Screen Shot 2018-11-07 at 11.48.01 AM.png

Article ID: 713940

Augustana University Professor’s Research Leads to Surprising Mating Decision in Butterfly Species

Augustana University, South Dakota

The males of one species of butterfly are more attracted to females that are active, not necessarily what they look like, according to a recent research conducted at Augustana University.The paper, “Behaviour before beauty: Signal weighting during mate selection in the butterfly Papilio polytes,” found that males of the species noticed the activity levels of potential female mates, not their markings.

Released:
8-Jul-2019 4:05 PM EDT
Newswise: Opening Science for Patients

Article ID: 715430

Opening Science for Patients

The Neuro - Montreal Neurological Institute and Hospital

Since being diagnosed with Parkinson’s disease (PD) six years ago at the age of 29, Ben Stecher has learned a lot about not just PD, but medical science in general. He has become a patient advocate in a field where the complexity of the science often shuts out anyone who doesn’t have a PhD.

Released:
8-Jul-2019 3:10 PM EDT
Newswise: New Animal Study Adds to Evidence of Parkinson’s Disease Origins in the Gut
  • Embargo expired:
    26-Jun-2019 11:00 AM EDT

Article ID: 714560

New Animal Study Adds to Evidence of Parkinson’s Disease Origins in the Gut

Johns Hopkins Medicine

In experiments in mice, Johns Hopkins Medicine researchers say they have found additional evidence that Parkinson’s disease originates among cells in the gut and travels up the body’s neurons to the brain. The study, described in the June issue of the journal Neuron, offers a new, more accurate model in which to test treatments that could prevent or halt Parkinson’s disease progression.

Released:
19-Jun-2019 8:00 AM EDT

Article ID: 714684

Pigs help scientists understand human brain

University of Georgia

For the first time, researchers in the University of Georgia's Regenerative Bioscience Center have used an imaging method normally reserved for humans to analyze brain activity in live agricultural swine models, and they have discovered that pig brains are even better platforms than previously thought for the study of human neurological conditions such as Alzheimer’s and Parkinson’s.

Released:
20-Jun-2019 11:05 AM EDT
Newswise: Study identifies promising target for Parkinson’s intervention

Article ID: 714292

Study identifies promising target for Parkinson’s intervention

University of Alabama at Birmingham

An international research team led by scientists at UAB has identified a fibril form of alpha-synuclein as a potential target for therapeutics that might help slow the progression of Parkinson’s disease.

Released:
12-Jun-2019 12:05 PM EDT
Newswise: Quatre millions de dollars pour le criblage de médicaments

Article ID: 714234

Quatre millions de dollars pour le criblage de médicaments

The Neuro - Montreal Neurological Institute and Hospital

L’Institut et hôpital neurologiques de Montréal (le Neuro) dirigera un partenariat en science ouverte en vue de la mise au point de médicaments de précision indiqués dans la sclérose latérale amyotrophique (SLA) et la maladie de Parkinson (MP).

Released:
11-Jun-2019 1:05 PM EDT
Newswise: $4M for open science drug screening

Article ID: 714233

$4M for open science drug screening

The Neuro - Montreal Neurological Institute and Hospital

The Neuro (Montreal Neurological Institute and Hospital) will lead an open science partnership to develop precision drugs for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).

Released:
11-Jun-2019 12:05 PM EDT

Showing results

110 of 133

Chat now!